Ameritas Investment Partners
DSGN icon

Ameritas Investment Partners’s Design Therapeutics DSGN Stock Holding History

Ameritas Investment Partners’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4K Buy
2,793
+223
+9% +$2.78K ﹤0.01% 2371
2026
Q1 		$27.3K Hold
2,570
– – ﹤0.01% 2446
2025
Q4 		$24.1K Hold
2,570
– – ﹤0.01% 2549
2025
Q3 		$19.4K Hold
2,570
– – ﹤0.01% 2676
2025
Q2 		$8.66K Hold
2,570
– – ﹤0.01% 3018
2025
Q1 		$9.92K Hold
2,570
– – ﹤0.01% 2827
2024
Q4 		$15.9K Hold
2,570
– – ﹤0.01% 2729
2024
Q3 		$13.8K Hold
2,570
– – ﹤0.01% 2820
2024
Q2 		$8.61K Hold
2,570
– – ﹤0.01% 2968
2024
Q1 		$10.4K Hold
2,570
– – ﹤0.01% 2805
2023
Q4 		$6.81K Hold
2,570
– – ﹤0.01% 2927
2023
Q3 		$6.07K Hold
2,570
– – ﹤0.01% 2957
2023
Q2 		$16.2K Hold
2,570
– – ﹤0.01% 2670
2023
Q1 		$14.8K Hold
2,570
– – ﹤0.01% 2568
2022
Q4 		$22K Hold
2,570
– – ﹤0.01% 2523
2022
Q3 		$42K Buy
2,570
+515
+25% +$10.2K ﹤0.01% 2108
2022
Q2 		$28K Hold
2,055
– – ﹤0.01% 2358
2022
Q1 		$33K Hold
2,055
– – ﹤0.01% 2293
2021
Q4 		$44K Buy
2,055
+998
+94% +$17.1K ﹤0.01% 2199
2021
Q3 		$16K Hold
1,057
– – ﹤0.01% 2799
2021
Q2 		$21K Buy
+1,057
New +$26.7K ﹤0.01% 2703

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's DSGN Position: Q2 2026 in Review

Ameritas Investment Partners increased its Design Therapeutics (DSGN) stake by 8.7% in Q2 2026, buying an estimated $2.78K and bringing the position to 2,793 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Ameritas Investment Partners first reported a position in DSGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $44K in Q4 2021. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Ameritas Investment Partners held 2,793 shares of Design Therapeutics worth $40.4K as of Q2 2026.
  • Ameritas Investment Partners bought 223 Design Therapeutics shares in Q2 2026, an estimated $2.78K.
  • Design Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2371 holding.
  • Ameritas Investment Partners first reported a position in Design Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Ameritas Investment Partners's Design Therapeutics position peaked at $44K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.